Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Therapeutic-area index

InflammationPeptide Trials.

Explore peptide clinical trials tagged to the inflammation condition group in the current local registry snapshot. Condition groups are PeptideStat search classifications layered over source-reported indications.

Studies
51
Recruiting
11
Completed
23
Results posted
8
Countries
32
Avg enrollment
320

Velocity

Inflammation trials by start year

Study start year · indexed snapshot

8642020062006: 2 trials2007: 0 trials2008: 1 trials2009: 1 trials20102010: 0 trials2011: 1 trials2012: 1 trials2013: 2 trials20142014: 1 trials2015: 1 trials2016: 2 trials2017: 2 trials20182018: 0 trials2019: 2 trials2020: 2 trials2021: 4 trials20222022: 1 trials2023: 7 trials2024: 6 trials2025: 8 trials20262026: 6 trials20272027: 1 trials

Development

Trials by phase

Early Phase 10
Phase 16
Phase 215
Phase 312
Phase 44

Industry

Leading sponsors

Eli Lilly5
4Moving Biotech2
Novo Nordisk2
Fapon Biotech Inc.1
Hudson Biotech1
KeyBioscience AG1
Sanofi1
Shire1

Therapeutic areas

Condition groups

Inflammation51
Weight loss11
Pain5
Brain health4
Type 2 diabetes2
Longevity1

Compound leaders

Most represented peptides.

01Calcitonin602Thymosin Alpha-1603Liraglutide504Nesiritide405Icatibant306Tirzepatide307Amycretin208Exenatide209Glucagon210Retatrutide211Teriparatide212Terlipressin2

Study explorer

Search this collection.

51 matching studies